FTC Rebukes Supernus Efforts To Block Sales Of Injector Pen For Use With Generic Apokyn

Agency refutes Supernus’ defense that Sage’s generic drug cartridges are ‘free-riding’ on the supply of the injector pen for its branded product. Company’s alleged exclusionary contract with pen distributor and pressure on specialty pharmacies not to provide the generic involve important antitrust issues, FTC tells court.

FTC building statue
FTC intervenes in antitrust complaint over Parkinson's disease treatment • Source: Shutterstock

More from Generics

More from Biosimilars & Generics